{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:14:19Z","timestamp":1785784459002,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malaria is a life-threatening parasitic disease caused by members of the genus  <jats:italic>Plasmodium<\/jats:italic>. The development and spread of drug-resistant strains of <jats:italic>Plasmodium<\/jats:italic> parasites represent a major challenge to malaria control and elimination programmes. Evaluating genetic polymorphism in a drug target improves our understanding of drug resistance and facilitates drug design. Approximately 450 and 19 whole-genome assemblies of <jats:italic>Plasmodium falciparum<\/jats:italic> and <jats:italic>Plasmodium vivax<\/jats:italic>, respectively, are currently available, and numerous sequence variations have been found due to the presence of single nucleotide polymorphism (SNP). In the study reported here, we analysed global SNPs in the malaria parasite aminoacyl-tRNA synthetases (aaRSs). Our analysis revealed 3182 unique SNPs in the 20 cytoplasmic <jats:italic>P. falciparum<\/jats:italic> aaRSs. Structural mapping of SNPs onto the three-dimensional inhibitor-bound complexes of the three advanced drug targets within aaRSs revealed a remarkably low mutation frequency in the crucial aminoacylation domains, low overall occurrence of mutations across samples and high conservation in drug\/substrate binding regions. In contrast to aaRSs, dihydropteroate synthase\u00a0(DHPS), also a malaria drug target, showed high occurrences of drug resistance-causing mutations.  Our results show that it is pivotal to screen potent malaria drug targets against global SNP profiles to assess genetic variances  to ensure success in designing drugs against validated targets and tackle drug resistance early on.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13071-022-05422-4","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T10:03:07Z","timestamp":1661853787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets"],"prefix":"10.1186","volume":"15","author":[{"given":"Jasmita","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"5422_CR1","unstructured":"WHO. Malaria. 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria. Accessed 20 Sept 2021."},{"key":"5422_CR2","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.2147\/IDR.S279433","volume":"13","author":"MA Shibeshi","year":"2020","unstructured":"Shibeshi MA, Kifle ZD, Atnafie SA. Antimalarial drug resistance and novel targets for antimalarial drug discovery. Infect Drug Resist. 2020;13:4047\u201360.","journal-title":"Infect Drug Resist"},{"key":"5422_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2021;385:1163\u201371.","journal-title":"N Engl J Med"},{"key":"5422_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.pt.2021.01.009","volume":"37","author":"T Yang","year":"2021","unstructured":"Yang T, Ottilie S, Istvan ES, Godinez-Macias KP, Lukens AK, Baraga\u00f1a B, et al. MalDA, accelerating malaria drug discovery. Trends Parasitol. 2021;37:493\u2013507.","journal-title":"Trends Parasitol"},{"key":"5422_CR5","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.2147\/DDDT.S265602","volume":"14","author":"MB Tafere","year":"2020","unstructured":"Tafere MB. Recent progress in the development of new antimalarial drugs with novel targets. Drug Des Devel Ther. 2020;14:3875\u201389.","journal-title":"Drug Des Devel Ther"},{"key":"5422_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/emmm.201100626","volume":"5","author":"P Yao","year":"2013","unstructured":"Yao P, Fox PL. Aminoacyl-tRNA synthetases in medicine and disease. EMBO Mol Med. 2013;5:332\u201343.","journal-title":"EMBO Mol Med"},{"key":"5422_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1186\/1471-2164-10-644","volume":"10","author":"TK Bhatt","year":"2009","unstructured":"Bhatt TK, Kapil C, Khan S, Jairajpuri MA, Sharma V, Santoni D, et al. A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum. BMC Genomics. 2009;10:644.","journal-title":"BMC Genomics"},{"key":"5422_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpddr.2013.10.001","volume":"4","author":"JS Pham","year":"2014","unstructured":"Pham JS, Dawson KL, Jackson KE, Lim EE, Pasaje CF, Turner KE, et al. Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites. Int J Parasitol Drugs Drug Resist. 2014;4:1\u201313.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5422_CR9","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.drudis.2018.01.050","volume":"23","author":"Y Manickam","year":"2018","unstructured":"Manickam Y, Chaturvedi R, Babbar P, Malhotra N, Jain V, Sharma A. Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum. Drug Discov Today. 2018;23:1233\u201340.","journal-title":"Drug Discov Today"},{"key":"5422_CR10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/pro.4148","volume":"30","author":"J Chhibber-Goel","year":"2021","unstructured":"Chhibber-Goel J, Yogavel M, Sharma A. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery. Protein Sci. 2021;30:1793\u2013803.","journal-title":"Protein Sci"},{"key":"5422_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10969-014-9182-1","volume":"15","author":"S Khan","year":"2014","unstructured":"Khan S, Sharma A, Belrhali H, Yogavel M, Sharma A. Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin. J Struct Funct Genomics. 2014;15:63\u201371.","journal-title":"J Struct Funct Genomics"},{"key":"5422_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005084","volume":"10","author":"A Sharma","year":"2016","unstructured":"Sharma A, Sharma M, Yogavel M, Sharma A. Protein translation enzyme lysyltRNA synthetase presents a new target for drug development against causative agents of loiasis and schistosomiasis. PLoS Negl Trop Dis. 2016;10:e0005084.","journal-title":"PLoS Negl Trop Dis"},{"key":"5422_CR13","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1002\/cbic.202100212","volume":"22","author":"P Babbar","year":"2021","unstructured":"Babbar P, Sato M, Manickam Y, Mishra S, Harlos K, Gupta S, et al. Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via a piperidine-ring scaffold inspired cladosporin analogues. ChemBioChem. 2021;22:2468\u201377.","journal-title":"ChemBioChem"},{"key":"5422_CR14","doi-asserted-by":"publisher","first-page":"11566","DOI":"10.1093\/nar\/gkaa862","volume":"48","author":"J Zhou","year":"2020","unstructured":"Zhou J, Huang Z, Zheng L, Hei Z, Wang Z, Yu B, et al. Inhibition of Plasmodium falciparum lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor. Nucleic Acids Res. 2020;48:11566\u201376.","journal-title":"Nucleic Acids Res"},{"key":"5422_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10969-014-9186-x","volume":"15","author":"V Jain","year":"2014","unstructured":"Jain V, Kikuchi H, Oshima Y, Sharma A, Yogavel M. Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase. J Struct Funct Genomics. 2014;15:181\u201390.","journal-title":"J Struct Funct Genomics"},{"key":"5422_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.str.2015.02.011","volume":"23","author":"V Jain","year":"2015","unstructured":"Jain V, Yogavel M, Oshima Y, Kikuchi H, Touquet B, Hakimi MA, et al. Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis. Structure. 2015;23:819\u201329.","journal-title":"Structure"},{"key":"5422_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.str.2017.07.015","volume":"25","author":"V Jain","year":"2017","unstructured":"Jain V, Yogavel M, Kikuchi H, Oshima Y, Hariguchi N, Matsumoto M, et al. Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis. Structure. 2017;25:1495-1505.e6.","journal-title":"Structure"},{"key":"5422_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41467-020-20478-5","volume":"12","author":"M Sharma","year":"2021","unstructured":"Sharma M, Malhotra N, Yogavel M, Harlos K, Melillo B, Comer E, et al. Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines. Nat Commun. 2021;12:343.","journal-title":"Nat Commun"},{"key":"5422_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07632","volume":"456","author":"MGE Network","year":"2008","unstructured":"The Malaria Genomic Epidemiology Network. A global network for investigating the genomic epidemiology of malaria. Nature. 2008;456:732\u20137.","journal-title":"Nature"},{"key":"5422_CR20","unstructured":"MalariaGEN. The Pf3K Project: pilot data release 3. 2015. http:\/\/www.malariagen.net\/data\/pf3k-3. Accessed 20 Sept 2021."},{"key":"5422_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11174","volume":"487","author":"M Manske","year":"2012","unstructured":"Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature. 2012;487:375\u20139.","journal-title":"Nature"},{"key":"5422_CR22","doi-asserted-by":"crossref","unstructured":"MalariaGEN, Ahouidi A, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amaratunga C, et al. An open dataset of\u00a0 Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Res. 2021;6:42. https:\/\/doi.org\/10.1186\/s13071-022-05422-4.","DOI":"10.1186\/s13071-022-05422-4"},{"key":"5422_CR23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ng.3599","volume":"48","author":"RD Pearson","year":"2016","unstructured":"Pearson RD, Amato R, Auburn S, Miotto O, Almagro-Garcia J, Amaratunga C, et al. Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat Genet. 2016;48:959\u201364.","journal-title":"Nat Genet"},{"key":"5422_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijid.2021.08.054","volume":"112","author":"J Gill","year":"2021","unstructured":"Gill J, Chakraborti S, Bharti P, Sharma A. Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine. Int J Infect Dis. 2021;112:35\u20139.","journal-title":"Int J Infect Dis"},{"key":"5422_CR25","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200180","volume":"10","author":"P Mittal","year":"2020","unstructured":"Mittal P, Mishra S, Kar S, Pande V, Sinha A, Sharma A. Global distribution of single amino acid polymorphisms in Plasmodium vivax Duffy-binding-like domain and implications for vaccine development efforts. Open Biol. 2020;10:200180.","journal-title":"Open Biol"},{"key":"5422_CR26","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","volume":"94","author":"T Triglia","year":"1997","unstructured":"Triglia T, Menting JG, Wilson C, Cowman AF. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA. 1997;94:13944\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5422_CR27","doi-asserted-by":"publisher","first-page":"14962","DOI":"10.1074\/jbc.RA118.004558","volume":"293","author":"M Yogavel","year":"2018","unstructured":"Yogavel M, Nettleship JE, Sharma A, Harlos K, Jamwal A, Chaturvedi R, et al. Structure of 6- hydroxymethyl-7,8-dihydropterin pyrophosphokinase-dihydropteroate synthase from Plasmodium vivax sheds light on drug resistance. J Biol Chem. 2018;293:14962\u201372.","journal-title":"J Biol Chem"},{"key":"5422_CR28","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1111\/febs.15196","volume":"287","author":"P Chitnumsub","year":"2020","unstructured":"Chitnumsub P, Jaruwat A, Talawanich Y, Noytanom K, Liwnaree B, Poen S, et al. The structure of Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase reveals the basis of sulfa resistance. FEBS J. 2020;287:3273\u201397.","journal-title":"FEBS J"},{"key":"5422_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijpara.2020.12.011","volume":"51","author":"R Chaturvedi","year":"2021","unstructured":"Chaturvedi R, Chhibber-Goel J, Verma I, Gopinathan S, Parvez S, Sharma A. Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites. Int J Parasitol. 2021;51:505\u201325.","journal-title":"Int J Parasitol"},{"key":"5422_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1107\/S0907444913001923","volume":"69","author":"S Khan","year":"2013","unstructured":"Khan S, Garg A, Camacho N, Van Rooyen J, Kumar Pole A, Belrhali H, et al. Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development. Acta Crystallogr D Biol Crystallogr. 2013;69:785\u201395.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"5422_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010363","volume":"18","author":"Y Manickam","year":"2022","unstructured":"Manickam Y, Malhotra N, Mishra S, Babbar P, Dusane A, Laleu B, et al. Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development. PLoS Pathog. 2022;18:e1010363.","journal-title":"PLoS Pathog"},{"key":"5422_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1432-1033.1994.00397.x","volume":"224","author":"DR Brooks","year":"1994","unstructured":"Brooks DR, Wang P, Read M, Watkins WM, Sims PF, Hyde JE. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 1994;224:397\u2013405.","journal-title":"Eur J Biochem"},{"key":"5422_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature19804","volume":"538","author":"N Kato","year":"2016","unstructured":"Kato N, Comer E, Sakata-Kato T, Sharma A, Sharma M, et al. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature. 2016;538:344\u20139.","journal-title":"Nature"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-022-05422-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-022-05422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T11:38:22Z","timestamp":1662118702000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-022-05422-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5422"],"URL":"https:\/\/doi.org\/10.1186\/s13071-022-05422-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"309"}}